{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Cefsulodin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefsulodin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefsulodin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "cefsulodin",
    "trial_2_text": "Cefsulodin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Cefsulodin Supplement: 60 participants will take Cefsulodin 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Cefsulodin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Cefsulodin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.20646332204341888,
      "78": 0.20395413041114807,
      "177": 0.16407863795757294,
      "123": 0.1414412409067154,
      "17": 0.13350369036197662,
      "9": 0.13144977390766144,
      "14": 0.12925492227077484,
      "37": 0.12360601127147675,
      "46": 0.12118372321128845,
      "173": 0.11951539665460587,
      "20": 0.11466052383184433,
      "21": 0.10575877875089645,
      "68": 0.0995708480477333,
      "79": 0.09949417412281036,
      "2": 0.09789697825908661,
      "77": 0.09509816020727158,
      "49": 0.09395842999219894,
      "189": 0.08977168798446655,
      "188": 0.08506809175014496,
      "67": 0.0848216712474823,
      "350": 0.08420119434595108,
      "200": 0.08141283690929413,
      "114": 0.08136554807424545,
      "228": 0.07995297014713287,
      "180": 0.0745350643992424,
      "72": 0.07054591178894043,
      "193": 0.06979746371507645,
      "64": 0.06858240813016891,
      "29": 0.06791453063488007,
      "126": 0.06781931221485138,
      "243": 0.06640297919511795,
      "76": 0.06609918177127838,
      "28": 0.06548051536083221,
      "86": 0.06468634307384491,
      "85": 0.06404003500938416,
      "104": 0.06372738629579544,
      "5": 0.06293730437755585,
      "27": 0.06226614862680435,
      "61": 0.06088891252875328,
      "239": 0.05666344612836838,
      "30": 0.055635005235672,
      "276": 0.05528634041547775,
      "179": 0.05476245656609535,
      "151": 0.05427323281764984,
      "131": 0.05312451347708702,
      "101": 0.053094349801540375,
      "139": 0.052591435611248016,
      "147": 0.05228235200047493,
      "144": 0.05136210843920708,
      "116": 0.049691274762153625,
      "194": 0.04949193075299263,
      "18": 0.048795606940984726,
      "102": 0.04870610311627388,
      "122": 0.04868003726005554,
      "82": 0.0470556765794754,
      "234": 0.04605347290635109,
      "269": 0.04501780495047569,
      "396": 0.04500921815633774,
      "1": 0.04378421977162361,
      "261": 0.04356154426932335,
      "92": 0.042441464960575104,
      "69": 0.042403820902109146,
      "282": 0.04238289222121239,
      "35": 0.04227474331855774,
      "132": 0.041578780859708786,
      "355": 0.04127829149365425,
      "204": 0.041257236152887344,
      "100": 0.04027493670582771,
      "38": 0.039619166404008865,
      "164": 0.03957236558198929,
      "253": 0.038477666676044464,
      "249": 0.037872083485126495,
      "441": 0.03763372823596001,
      "96": 0.03690289705991745,
      "262": 0.03666913881897926,
      "221": 0.03653353825211525,
      "186": 0.036506131291389465,
      "75": 0.03605198860168457,
      "508": 0.035636600106954575,
      "191": 0.03494183346629143,
      "36": 0.03474245220422745,
      "466": 0.03424903005361557,
      "288": 0.03349115327000618,
      "130": 0.033469196408987045,
      "142": 0.031133277341723442,
      "97": 0.03099929727613926,
      "153": 0.030799828469753265,
      "212": 0.03043190948665142,
      "4": 0.030305804684758186,
      "339": 0.02981382980942726,
      "400": 0.02969263307750225,
      "361": 0.02958839386701584,
      "268": 0.029435183852910995,
      "286": 0.02923542819917202,
      "154": 0.029179953038692474,
      "341": 0.029168345034122467,
      "494": 0.02909051440656185,
      "98": 0.02907039411365986,
      "31": 0.02882234938442707,
      "202": 0.028476493433117867
    },
    "trial_2_ae": {
      "87": 0.20646332204341888,
      "78": 0.20395413041114807,
      "177": 0.16407863795757294,
      "123": 0.1414412409067154,
      "17": 0.13350369036197662,
      "9": 0.13144977390766144,
      "14": 0.12925492227077484,
      "37": 0.12360601127147675,
      "46": 0.12118372321128845,
      "173": 0.11951539665460587,
      "20": 0.11466052383184433,
      "21": 0.10575877875089645,
      "68": 0.0995708480477333,
      "79": 0.09949417412281036,
      "2": 0.09789697825908661,
      "77": 0.09509816020727158,
      "49": 0.09395842999219894,
      "189": 0.08977168798446655,
      "188": 0.08506809175014496,
      "67": 0.0848216712474823,
      "350": 0.08420119434595108,
      "200": 0.08141283690929413,
      "114": 0.08136554807424545,
      "228": 0.07995297014713287,
      "180": 0.0745350643992424,
      "72": 0.07054591178894043,
      "193": 0.06979746371507645,
      "64": 0.06858240813016891,
      "29": 0.06791453063488007,
      "126": 0.06781931221485138,
      "243": 0.06640297919511795,
      "76": 0.06609918177127838,
      "28": 0.06548051536083221,
      "86": 0.06468634307384491,
      "85": 0.06404003500938416,
      "104": 0.06372738629579544,
      "5": 0.06293730437755585,
      "27": 0.06226614862680435,
      "61": 0.06088891252875328,
      "239": 0.05666344612836838,
      "30": 0.055635005235672,
      "276": 0.05528634041547775,
      "179": 0.05476245656609535,
      "151": 0.05427323281764984,
      "131": 0.05312451347708702,
      "101": 0.053094349801540375,
      "139": 0.052591435611248016,
      "147": 0.05228235200047493,
      "144": 0.05136210843920708,
      "116": 0.049691274762153625,
      "194": 0.04949193075299263,
      "18": 0.048795606940984726,
      "102": 0.04870610311627388,
      "122": 0.04868003726005554,
      "82": 0.0470556765794754,
      "234": 0.04605347290635109,
      "269": 0.04501780495047569,
      "396": 0.04500921815633774,
      "1": 0.04378421977162361,
      "261": 0.04356154426932335,
      "92": 0.042441464960575104,
      "69": 0.042403820902109146,
      "282": 0.04238289222121239,
      "35": 0.04227474331855774,
      "132": 0.041578780859708786,
      "355": 0.04127829149365425,
      "204": 0.041257236152887344,
      "100": 0.04027493670582771,
      "38": 0.039619166404008865,
      "164": 0.03957236558198929,
      "253": 0.038477666676044464,
      "249": 0.037872083485126495,
      "441": 0.03763372823596001,
      "96": 0.03690289705991745,
      "262": 0.03666913881897926,
      "221": 0.03653353825211525,
      "186": 0.036506131291389465,
      "75": 0.03605198860168457,
      "508": 0.035636600106954575,
      "191": 0.03494183346629143,
      "36": 0.03474245220422745,
      "466": 0.03424903005361557,
      "288": 0.03349115327000618,
      "130": 0.033469196408987045,
      "142": 0.031133277341723442,
      "97": 0.03099929727613926,
      "153": 0.030799828469753265,
      "212": 0.03043190948665142,
      "4": 0.030305804684758186,
      "339": 0.02981382980942726,
      "400": 0.02969263307750225,
      "361": 0.02958839386701584,
      "268": 0.029435183852910995,
      "286": 0.02923542819917202,
      "154": 0.029179953038692474,
      "341": 0.029168345034122467,
      "494": 0.02909051440656185,
      "98": 0.02907039411365986,
      "31": 0.02882234938442707,
      "202": 0.028476493433117867
    }
  },
  "safety": {
    "trial_1_safety": 0.3269039988517761,
    "trial_2_safety": 0.3269039988517761
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47792160511016846
  }
}